Chemical Component Summary

Name9ALPHA-FLUOROCORTISOL
Identifiers(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyethanoyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
FormulaC21 H29 F O5
Molecular Weight380.45
TypeNON-POLYMER
Isomeric SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F
InChIInChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1
InChIKeyAAXVEMMRQDVLJB-BULBTXNYSA-N

Chemical Details

Formal Charge0
Atom Count56
Chiral Atom Count7
Bond Count59
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00687 
NameFludrocortisone
Groups
  • approved
  • investigational
DescriptionFludrocortisone is a synthetic mineralocorticoid used in conjunction with [hydrocortisone] to replace missing endogenous corticosteroids in patients with adrenal insufficiency.[A187169,A187187] It is functionally similar to [aldosterone], the body's primary endogenous mineralocorticoid, and is structurally analogous to [cortisol], differing only by a fluorine atom at the 9-position of the steroid structure - this fluorination is thought to be crucial to fludrocortisone's significant mineralocorticoid potency.[A5423]
Synonyms
  • 9alpha-Fluorocortisol
  • Fludrocortisonum
  • Fludrocortison
  • Fluohydrocortisone
  • Fludrocortisone
Brand Names
  • Florinef
  • Florinef Acetate
  • Truemed Group LLC
  • Fludrocortisone Acetate
  • Florinef Acetate 0.1mg
IndicationFludrocortisone is indicated as partial replacement therapy for primary or secondary adrenocortical insufficiency in Addison's disease. It is also indicated for the treatment of salt-losing androgenital syndrome.[L8971]
Categories
  • 11-Hydroxycorticosteroids
  • 17-Hydroxycorticosteroids
  • Adrenal Cortex Hormones
  • Adrenals
  • Anti-Inflammatory Agents
ATC-Code
  • S02CA07
  • S01CA06
  • H02AA02
  • S03CA05
CAS number127-31-1

Drug Targets

NameTarget SequencePharmacological ActionActions
Mineralocorticoid receptorMETKGYHSLPEGLDMERRWGQVSQAVERSSLGPTERTDENNYMEIVNVSC...unknownagonist
Glucocorticoid receptorMDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAV...unknownagonist
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Corticosteroid 11-beta-dehydrogenase isozyme 2MERWPWPSGGAWLLVAARALLQLLRSDLRLGRPLLAALALLAALDWLCQR...unknownsubstrate
Corticosteroid 11-beta-dehydrogenase isozyme 1MAFMKKYLLPILGLFMAYYYYSANEEFRPEMLQGKKVIVTGASKGIGREM...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 31378
ChEMBL CHEMBL1201388
ChEBI CHEBI:50885
CCDC/CSD FPRTOD10